Detail akcie FUJIFILM Holding Depository Receipt online

Business Summary: FUJIFILM Holdings Corporation is engaged in the development, production, sales and service of imaging solutions, information solutions and document solutions. The Company's segments include Imaging Solutions, Information Solutions, Document Solutions and, Corporate expenses and eliminations. The Imaging Solutions segment consists of photo imaging, and optical device and electronic imaging products. The Information Solutions segment includes products used in medical systems, pharmaceuticals, regenerative medicine, life sciences, flat panel display (FPD) materials, industrial products, electronic materials, recording media and graphic systems. The Document Solutions segment includes office products, office printers, production services and global services. The Company's products include FUJI DRI-CHEM IMMUNO AG1, LASEREO, SYNAPSE Vendor Neutral Archive (VNA), FDR D-EVO II, SonoSite iViz, X FUJIFILM Index, FUJIFILM X-T2 and Instax Cameras Index.
Financial Summary: BRIEF: For the three months ended 30 June 2024, FUJIFILM Holdings Corp. (ADR) revenues increased 13% to Y749.02B. Net income applicable to common stockholders increased 12% to Y60.68B. Revenues reflect Business innovation segment increase of 44% to Y280.02B, Imaging segment increase of 24% to Y130.68B, Healthcare segment increase of 11% to Y229.19B, Europe segment increase of 49% to Y133.73B, Asia And Other segment increase of 19% to Y220.65B.